Latest Cancer News

DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial (09-19-2014)
DNAtrix, Inc., experts in oncolytic virus development, today announced that the first patient was treated with the company’s lead product, DNX-2401, a replication competent adenovirus plus gamma... Continue Reading

Bayer and Orion Initiate Phase III Trial of Novel Prostate Cancer Agent ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (09-18-2014)
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational novel oral androgen receptor... Continue Reading

Breast Conservation Therapy May Be Better than a Mastectomy (09-17-2014)
Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage... Continue Reading

More Cancer News

Locations

COLCHESTER
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
792 College Parkway, Suite 207
Colchester, Vermont   05446
TEL: (802) 655-3400
FAX: (802) 655-9170

ST ALBANS
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
4 Crest Road,
St. Albans, VT 05478
TEL: (802) 524-0537
FAX: (802) 524-0538

MIDDLEBURY
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
110 Porter Drive,
Middlebury, VT 05753
TEL: (802) 388-8977
FAX: (802) 388-8976